The prevalence of transthyretin amyloidosis in patients with heart failure with preserved ejection fraction

被引：0
|
作者：
Oh, J. Jaewon [1 ]
Kim, S. E. [1 ]
Lee, S. [1 ]
Lee, C. J. [1 ]
Kang, S. M. [1 ]
机构：
[1] Yonsei Univ, Seoul, South Korea
来源：
EUROPEAN JOURNAL OF HEART FAILURE | 2023年 / 25卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：359 / 359
页数：1
相关论文
共 50 条
  • [1] Prevalence of transthyretin amyloidosis in patients with heart failure with preserved ejection fraction
    Naito, T.
    Nakamura, K.
    Abe, Y.
    Sakuragi, S.
    Kihara, H.
    Okizaki, A.
    Kawai, Y.
    Watanabe, H.
    Yoshikawa, M.
    Takaishi, A.
    Fujio, H.
    Otsuka, H.
    Ogura, S.
    Nomura, N.
    Ito, H.
    [J]. EUROPEAN HEART JOURNAL, 2022, 43 : 1079 - 1079
  • [2] Prevalence of transthyretin amyloidosis among heart failure patients with preserved ejection fraction in Japan
    Naito, Takanori
    Nakamura, Kazufumi
    Abe, Yukio
    Watanabe, Hiroyuki
    Sakuragi, Satoru
    Katayama, Yusuke
    Kihara, Hajime
    Okizaki, Atsutaka
    Kawai, Yusuke
    Yoshikawa, Masaki
    Takaishi, Atsushi
    Fujio, Hideki
    Otsuka, Hiroaki
    Ogura, Soichiro
    Ito, Hiroshi
    [J]. ESC HEART FAILURE, 2023, 10 (03): : 1896 - 1906
  • [3] Transthyretin Cardiac Amyloidosis in Patients With Acute Heart Failure and Preserved Ejection Fraction
    Horvath, Sofia A.
    Lo Presti, Saberio
    McCloskey, Veronica
    Mihos, Christos G.
    Santana, Orlando
    [J]. CIRCULATION, 2018, 138
  • [4] PREVALENCE OF TRANSTHYRETIN CARDIAC AMYLOIDOSIS IN HEART FAILURE WITH PRESERVED EJECTION FRACTION: A POPULATION BASED STUDY
    Abou-Ezzeddine, Omar Farid
    Davies, Daniel
    Sexton, Jasmine A.
    Scott, Christopher G.
    Fayyaz, Ahmed
    Akhiyat, Nadia
    Stromme, Trevor A.
    Askew, John W.
    McKie, Paul
    Noseworthy, Peter
    Dunlay, Shannon
    Borlaug, Barry
    Chareonthaitawee, Panithaya
    Johnson, Geoffrey
    Dispenzieri, Angela
    Grogan, Martha
    Redfield, Margaret M.
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2020, 75 (11) : 691 - 691
  • [5] Transthyretin cardiac amyloidosis: A treatable form of heart failure with a preserved ejection fraction
    Griffin, Jan M.
    Maurer, Mathew S.
    [J]. TRENDS IN CARDIOVASCULAR MEDICINE, 2021, 31 (01) : 59 - 66
  • [6] A systematic review and meta-analysis of the prevalence of transthyretin amyloidosis in heart failure with preserved ejection fraction
    Magdi, Mohamed
    Mostafa, Mostafa Reda
    Abusnina, Waiel
    Al-abdouh, Ahmad
    Doss, Ramy
    Mohamed, Sarah
    Ekpo, Chidera Philippa
    Alweis, Richard
    Baibhav, Bipul
    [J]. AMERICAN JOURNAL OF CARDIOVASCULAR DISEASE, 2022, 12 (03): : 102 - +
  • [7] OBSERVATIONAL STUDY TO DETERMINE THE PREVALENCE OF TRANSTHYRETIN AMYLOIDOSIS IN AN UNDIFFERENTIATED HEART FAILURE WITH PRESERVED EJECTION FRACTION POPULATION
    Giblin, G.
    Gray, A.
    Murphy, L.
    Kavanagh, E.
    Tracey, C.
    Howley, C.
    Murphy, N.
    O'Neill, J.
    O'Connell, M.
    Coyne, M.
    Joyce, E.
    Mahon, N.
    [J]. HEART, 2020, 106 : A24 - A24
  • [8] Prevalence of Transthyretin Amyloid Cardiomyopathy in Heart Failure With Preserved Ejection Fraction
    AbouEzzeddine, Omar F.
    Davies, Daniel R.
    Scott, Christopher G.
    Fayyaz, Ahmed U.
    Askew, J. Wells
    McKie, Paul M.
    Noseworthy, Peter A.
    Johnson, Geoffrey B.
    Dunlay, Shannon M.
    Borlaug, Barry A.
    Chareonthaitawee, Panithaya
    Roger, Veronique L.
    Dispenzieri, Angela
    Grogan, Martha
    Redfield, Margaret M.
    [J]. JAMA CARDIOLOGY, 2021, 6 (11) : 1267 - 1274
  • [9] High prevalence of heart failure with reduced ejection fraction in patients with transthyretin cardiac amyloidosis
    Talal Asif
    Tiago Araujo
    Vasvi Singh
    Saurabh Malhotra
    [J]. Journal of Nuclear Cardiology, 2020, 27 : 1044 - 1046
  • [10] High prevalence of heart failure with reduced ejection fraction in patients with transthyretin cardiac amyloidosis
    Asif, Talal
    Araujo, Tiago
    Singh, Vasvi
    Malhotra, Saurabh
    [J]. JOURNAL OF NUCLEAR CARDIOLOGY, 2020, 27 (03) : 1044 - 1046
12345